Trial
NCT05543707
PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Pardes Biosciences, Inc.
Collaborators
—
Condition
COVID-19
Intervention
PBI-0451 (Pomotrelvir)
Why stopped
Interim analysis concluded primary endpoint was not met
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-11